| ZÁVADA, Jakub, Michal UHER, Katarina SISOL, Šárka FOREJTOVÁ, Kateřina JAROŠOVÁ, Heřman F. MANN, Jiří VENCOVSKÝ a Karel PAVELKA. A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. In ARTHRITIS & RHEUMATOLOGY. ISSN 2326-5191. 2014. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1299405,
author = {Závada, Jakub and Uher, Michal and Sisol, Katarina and Forejtová, Šárka and Jarošová, Kateřina and Mann, Heřman F. and Vencovský, Jiří and Pavelka, Karel},
booktitle = {ARTHRITIS & RHEUMATOLOGY},
title = {A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.},
year = {2014}
}
TY - CONF
ID - 1299405
AU - Závada, Jakub - Uher, Michal - Sisol, Katarina - Forejtová, Šárka - Jarošová, Kateřina - Mann, Heřman F. - Vencovský, Jiří - Pavelka, Karel
PY - 2014
TI - A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.
ER -
ZÁVADA, Jakub, Michal UHER, Katarina SISOL, Šárka FOREJTOVÁ, Kateřina JAROŠOVÁ, Heřman F. MANN, Jiří VENCOVSKÝ a Karel PAVELKA. A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study. In \textit{ARTHRITIS \&{} RHEUMATOLOGY}. ISSN~2326-5191. 2014.
|
